You have 9 free searches left this month | for more free features.

City

Qingdao (1)

Worcester (1)

Condition

AMN (1)

AMN Gene Mutation (1)

Healthy Subjects (1)

X-ALD (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

SwanBio Therapeutics, Inc. (1)

The Affiliated Hospital of Qingdao University (1)

Collaborator

Intervention

amlodipine 10 mg (1)

imitation procedure (1)

levamlodipine 5 mg (1)

sbt101 (1)

Study Documents

Intervention Type

drug (1)

genetic (1)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

ALDP

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting

AMN
+2 more

SBT101
Imitation Procedure

Worcester, Massachusetts

University of Massachusetts Chan Medical School

Jun 1, 2022

Healthy Subjects Trial in Qingdao (Amlodipine 10 mg, Levamlodipine 5 mg)

Completed

Healthy Subjects

Amlodipine 10 mg
Levamlodipine 5 mg

Qingdao, Shandong, China

Phase Ⅰ Clinical Research Center

Jun 3, 2020